Indaba Capital Management, L.P. Quant / Systematic

CIK: 0001524362 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value ($000): $154,899 (59.4% shares, 40.6% debt)

Holdings (7)

— EQUITY COMWLTH 33.8%

Value ($000) $52,380 Shares 2,700,000 Est. Cost $19.40 Unrealized —

— BANDWIDTH INC 23.9%

Value ($000) $36,987 Shares 49,250,000 Est. Cost $0.62 Unrealized —

ONTF ON24 INC 16.5%

Value ($000) $25,484 Shares 4,240,256 Est. Cost $22.91 Unrealized -72.3%

BL BLACKLINE INC 9.1%

Value ($000) $14,147 Shares 292,000 Est. Cost $54.92 Unrealized 0.0%

— XOMETRY INC 8.6%

Value ($000) $13,371 Shares 17,750,000 Est. Cost $0.75 Unrealized —

— ACCELERATE DIAGNOSTICS INC 7.5%

Value ($000) $11,604 Shares 24,083,901 Est. Cost $0.64 Unrealized —

— ESPERION THERAPEUTICS INC NE 0.6%

Value ($000) $926 Shares 1,000,000 Est. Cost $0.93 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	EQUITY COMWLTH	2,700,000	$52,380	33.8%	$19.40	—	COM SH BEN INT	294628102
—	BANDWIDTH INC	49,250,000	$36,987	23.9%	$0.62	—	NOTE 0.500% 4/0	05988JAD5
ONTF	ON24 INC	4,240,256	$25,484	16.5%	$22.91	-72.3%	COM	68339B104
BL	BLACKLINE INC	292,000	$14,147	9.1%	$54.92	0.0%	COM	09239B109
—	XOMETRY INC	17,750,000	$13,371	8.6%	$0.75	—	NOTE 1.000% 2/0	98423FAB5
—	ACCELERATE DIAGNOSTICS INC	24,083,901	$11,604	7.5%	$0.64	—	NOTE 5.000%12/1	00430HAC6
—	ESPERION THERAPEUTICS INC NE	1,000,000	$926	0.6%	$0.93	—	NOTE 4.000%11/1	29664WAB1